Starboard has a roughly $1 billion stake in the drugmaker and approached former Pfizer CEO Ian Read and ex-CFO Frank D'Amelio, both of whom expressed interest in supporting the activist investor's ...
Pfizer chief executive Albert Bourla plans to meet Starboard Value, said people familiar with the matter, as the activist investor’s $1bn stake in the pharmaceutical group puts pressure on its board ...
Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...
Zacks.com on MSN3h
Pfizer Receives $1 Billion From Starboard Value, Stock RisesShares of Pfizer PFE rose 2.17% on Oct. 7 after a report from The Wall Street Journal stated that activist investor Starboard ...
The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
The two companies brought legal action over a repeated sequence in the messenger RNA (mRNA) used in CureVac's patents in life ...
As activist Starboard teams up with former Pfizer executives, the pharma giant’s lack of focus is in the spotlight.
Pfizer in recent months has implemented aggressive cost-cutting measures to help it weather the steep decline in sales of its ...
A trade group representing large compounding pharmacies sued the FDA over its removal of a widely prescribed Lilly diabetes ...
Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...
The Centers for Disease Control and Prevention (CDC) currently recommends that everyone aged 6 months and up get the Moderna or Pfizer COVID-19 vaccines. The Novavax vaccine is authorized by the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback